Conference Reports for NATAP

HIV Glasgow 2020, 5-8 October Virtual Meeting Back

Tweet

Lenacapavir Resistance Analysis in a Phase 1b Clinical Proof-Of-Concept Study       HIV Drug Therapy, October 5-8, 2020, Glasgow, UK Reported by Jules Levin   Margot, Renee Ram, PC Parvangada, Ross Martin, Rob Hyland, Martin Rhee, Christian Callebaut Gilead Sciences, Inc., Foster City, California, USA